Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes (2024) Faiez Zannad

Description

This review discusses the importance of early detection of chronic kidney disease (CKD) in persons with Type 2 diabetes and outlines a four-pillar pharmacological approach (including RAS inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, and finerenone) aimed at slowing CKD progression and reducing associated cardiovascular risk.